Table 1

Characteristics of the patients at baseline

Characteristicsn (%) or mean (SD)
Female gender260 (92.5)
Age at diagnosis, years35.8 (13.3)
Disease duration, years7.0 (3.9)
SLEDAI-2K1.4 (2.5)
SDI1.3 (1.5)
Prednisone daily dose, mg/day2.1 (3.4)
Antimalarial use
Never10 (3.6)
Past19 (6.8)
Current252 (89.7)
Immunosuppressive drug use
Never61 (21.7)
Past70 (24.9)
Current150 (53.4)
  • SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2K.